The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. BPC 157 + TB 500 Blend 20mg Research Peptide PRG TRANSLATING THE BIOLOGY OF AGING INTO NEW THERAPEUTICS FOR ALZHEIMER'S DISEASE: SENOLYTICS The Journal of Prevention of Alzheimer's Disease The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications BPC 157 + TB 500 blend (1 injection) 10 mg 10 mg BT 7 BPC 157 Supports Recovery, Gut Health & Regeneration
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols